Submitted: 09 Jan 2023
Accepted: 06 Mar 2023
ePublished: 16 May 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Ren Endocrinol. 2023;9: e25081.
doi: 10.34172/jre.2023.25081
  Abstract View: 607
  PDF Download: 214


Allopurinol and renal impairment; as review on current findings

Sina Bakhshaei 1, Bina Bakhshaei 2 ORCID logo, Rastina Mehrani 3 ORCID logo, Sina Neshat 4 ORCID logo, Zeinab Rezvani 5, Sara Dehghan 6 ORCID logo, Hossein Mardanparvar 6 ORCID logo, Mahnaz Momenzadeh 5* ORCID logo

1 Internal Medicine Department, UHS SoCal Medical Education Consortium Temecula, Ca, USA.
2 Neurology Department, Median Klinik NRZ, Wiesbaden, Germany.
3 School of Medicine, St George University, Grenada, West Indies.
4 Department of Pulmonology, Mayo Clinic, Jacksonville 32224 FL, USA.
5 Nickan Research Institute, Isfahan, Iran.
6 Department of Nursing, Faculty of Nursing and Midwifery, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
*Corresponding Author: Mahnaz Momenzadeh, Email: Mahnazmomenzadehf@gmail.com, , Email: Mahnaz.momenzadeh@pharm.mui.ac.ir


Hyperuricemia is described as a serum uric acid level more than 6.0 mg/dL. It is demonstrated by basic research and clinical studies, which the elevation of uric acid level may change the renal histology and function by developing acute and chronic kidney diseases (CKDs), diabetic nephropathy and end-stage renal disease (ESRD). There is no doubt about a significant relationship between uric acid and renal impairment. However, the details of this correlation, especially; between uric acid and renal failure, are discussable. Renal vasoconstriction, antiangiogenic properties, endothelial dysfunction, proinflammatory properties, renal fibrosis, pro-oxidative properties, and alteration of renal autoregulation are the most common mechanisms, which approve the association between uric acid and renal impairment. Allopurinol administration for CKD treatment in patients with gout is one of the most discussable challenges. It should be investigated whether allopurinol can diminish the deterioration of the glomerular filtration rate (GFR) in CKD patients who are at risk of ESRD. Some previous studies reported that allopurinol decreases the CKD incident risk, but others could not confirm this association. The benefit or risks of allopurinol in different stages of CKD, dialysis, and renal transplant are discussed in this study.

Citation: Bakhshaei S, Bakhshaei B, Mehrani R, Neshat S, Rezvani Z, Dehghan S, Mardanparvar H, Momenzadeh M. Allopurinol and renal impairment; as review on current findings. J Ren Endocrinol. 2023;9:e25081. doi: 10.34172/jre.2023.25081.
First Name
Last Name
Email Address
Security code

Abstract View: 608

Your browser does not support the canvas element.

PDF Download: 214

Your browser does not support the canvas element.